The effects of estrogen on blood coagulation, anticoagulation, and fibrinolysis in gynecologic benign diseases: A prospective study.
Not Applicable
Recruiting
- Conditions
- gynecologic benign diseases
- Registration Number
- JPRN-UMIN000044081
- Lead Sponsor
- Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
Patients medicated with antiplatelets or anticoagulants. Patients affected by venous thromboembolism. Patients complicated with diseases involving platelets, coagulation, fibrinolysis, anticoagulation, or antifibrinolysis system. Patients with anemia (Hb< 8.0 g/dL). Patients after menopause. Patients with serious liver disease (or AST <= 100 U/L). Patients with severe renal disease (or serum creatinine <= 1.3 mg/dL). Pregnant women. Women during lactation.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The parameters of Rotational thromboelastometry and Endogenous thrombin potential-based activated protein C sensitivity ratio.
- Secondary Outcome Measures
Name Time Method